世界のマイクロRNA市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV12686)
◆英語タイトル:Global MicroRNA Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV12686
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:125
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはマイクロRNAの世界市場について調査・分析した資料です。種類別(PCRベースアッセイ、miRNAアレイ、次世代シーケンシング(NGS)、イムノアッセイ)の市場規模、用途別(診断センター、学術・研究機関、生物製薬会社、委託研究機関)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別マイクロRNAの競争状況、市場シェア
・世界のマイクロRNA市場:種類別市場規模 2015年-2020年(PCRベースアッセイ、miRNAアレイ、次世代シーケンシング(NGS)、イムノアッセイ)
・世界のマイクロRNA市場:種類別市場規模予測 2021年-2026年(PCRベースアッセイ、miRNAアレイ、次世代シーケンシング(NGS)、イムノアッセイ)
・世界のマイクロRNA市場:用途別市場規模 2015年-2020年(診断センター、学術・研究機関、生物製薬会社、委託研究機関)
・世界のマイクロRNA市場:用途別市場規模予測 2021年-2026年(診断センター、学術・研究機関、生物製薬会社、委託研究機関)
・北米のマイクロRNA市場分析:米国、カナダ
・ヨーロッパのマイクロRNA市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのマイクロRNA市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のマイクロRNA市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのマイクロRNA市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Illumina、Roche、Agilent、Bio-Rad、Sigma Aldrich、Qiagen、Thermo Fisher Scientific、HTG Molecular Diagnostics、Meridian Life Science、Rosetta Genomics、Dharmacon、BioVendor、Miltenyi Biotec、Kaneka Corporation、Abcam、GeneCopoeia、Promega Corporation、New England Biolabs、NanoString Technologies
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

A microRNA (abbreviated miRNA) is a small non-coding RNA molecule (containing about 22 nucleotides) found in plants, animals and some viruses, that functions in RNA silencing and post-transcriptional regulation of gene expression.
PCR based arrays dominated the global microRNA market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.

Market Analysis and Insights: Global MicroRNA Market
The global MicroRNA market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global MicroRNA Scope and Market Size
MicroRNA market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global MicroRNA market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Illumina
Roche
Agilent
Bio-Rad
Sigma Aldrich
Qiagen
Thermo Fisher Scientific
HTG Molecular Diagnostics
Meridian Life Science
Rosetta Genomics
Dharmacon
BioVendor
Miltenyi Biotec
Kaneka Corporation
Abcam
GeneCopoeia
Promega Corporation
New England Biolabs
NanoString Technologies

Market segment by Type, the product can be split into
PCR-based Assay
miRNA Arrays
Next Generation Sequencing (NGS)
Immunoassay
Market segment by Application, split into
Diagnostic Centers
Academic and Research Institutes
Biopharmaceutical Companies
Contract Research Organizations

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by MicroRNA Revenue
1.4 Market by Type
1.4.1 Global MicroRNA Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 PCR-based Assay
1.4.3 miRNA Arrays
1.4.4 Next Generation Sequencing (NGS)
1.4.5 Immunoassay
1.5 Market by Application
1.5.1 Global MicroRNA Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Centers
1.5.3 Academic and Research Institutes
1.5.4 Biopharmaceutical Companies
1.5.5 Contract Research Organizations
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global MicroRNA Market Perspective (2015-2026)
2.2 Global MicroRNA Growth Trends by Regions
2.2.1 MicroRNA Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 MicroRNA Historic Market Share by Regions (2015-2020)
2.2.3 MicroRNA Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 MicroRNA Market Growth Strategy
2.3.6 Primary Interviews with Key MicroRNA Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top MicroRNA Players by Market Size
3.1.1 Global Top MicroRNA Players by Revenue (2015-2020)
3.1.2 Global MicroRNA Revenue Market Share by Players (2015-2020)
3.1.3 Global MicroRNA Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global MicroRNA Market Concentration Ratio
3.2.1 Global MicroRNA Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by MicroRNA Revenue in 2019
3.3 MicroRNA Key Players Head office and Area Served
3.4 Key Players MicroRNA Product Solution and Service
3.5 Date of Enter into MicroRNA Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global MicroRNA Historic Market Size by Type (2015-2020)
4.2 Global MicroRNA Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global MicroRNA Market Size by Application (2015-2020)
5.2 Global MicroRNA Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America MicroRNA Market Size (2015-2020)
6.2 MicroRNA Key Players in North America (2019-2020)
6.3 North America MicroRNA Market Size by Type (2015-2020)
6.4 North America MicroRNA Market Size by Application (2015-2020)

7 Europe
7.1 Europe MicroRNA Market Size (2015-2020)
7.2 MicroRNA Key Players in Europe (2019-2020)
7.3 Europe MicroRNA Market Size by Type (2015-2020)
7.4 Europe MicroRNA Market Size by Application (2015-2020)

8 China
8.1 China MicroRNA Market Size (2015-2020)
8.2 MicroRNA Key Players in China (2019-2020)
8.3 China MicroRNA Market Size by Type (2015-2020)
8.4 China MicroRNA Market Size by Application (2015-2020)

9 Japan
9.1 Japan MicroRNA Market Size (2015-2020)
9.2 MicroRNA Key Players in Japan (2019-2020)
9.3 Japan MicroRNA Market Size by Type (2015-2020)
9.4 Japan MicroRNA Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia MicroRNA Market Size (2015-2020)
10.2 MicroRNA Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia MicroRNA Market Size by Type (2015-2020)
10.4 Southeast Asia MicroRNA Market Size by Application (2015-2020)

11 India
11.1 India MicroRNA Market Size (2015-2020)
11.2 MicroRNA Key Players in India (2019-2020)
11.3 India MicroRNA Market Size by Type (2015-2020)
11.4 India MicroRNA Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America MicroRNA Market Size (2015-2020)
12.2 MicroRNA Key Players in Central & South America (2019-2020)
12.3 Central & South America MicroRNA Market Size by Type (2015-2020)
12.4 Central & South America MicroRNA Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Illumina
13.1.1 Illumina Company Details
13.1.2 Illumina Business Overview
13.1.3 Illumina MicroRNA Introduction
13.1.4 Illumina Revenue in MicroRNA Business (2015-2020))
13.1.5 Illumina Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche MicroRNA Introduction
13.2.4 Roche Revenue in MicroRNA Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Agilent
13.3.1 Agilent Company Details
13.3.2 Agilent Business Overview
13.3.3 Agilent MicroRNA Introduction
13.3.4 Agilent Revenue in MicroRNA Business (2015-2020)
13.3.5 Agilent Recent Development
13.4 Bio-Rad
13.4.1 Bio-Rad Company Details
13.4.2 Bio-Rad Business Overview
13.4.3 Bio-Rad MicroRNA Introduction
13.4.4 Bio-Rad Revenue in MicroRNA Business (2015-2020)
13.4.5 Bio-Rad Recent Development
13.5 Sigma Aldrich
13.5.1 Sigma Aldrich Company Details
13.5.2 Sigma Aldrich Business Overview
13.5.3 Sigma Aldrich MicroRNA Introduction
13.5.4 Sigma Aldrich Revenue in MicroRNA Business (2015-2020)
13.5.5 Sigma Aldrich Recent Development
13.6 Qiagen
13.6.1 Qiagen Company Details
13.6.2 Qiagen Business Overview
13.6.3 Qiagen MicroRNA Introduction
13.6.4 Qiagen Revenue in MicroRNA Business (2015-2020)
13.6.5 Qiagen Recent Development
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Details
13.7.2 Thermo Fisher Scientific Business Overview
13.7.3 Thermo Fisher Scientific MicroRNA Introduction
13.7.4 Thermo Fisher Scientific Revenue in MicroRNA Business (2015-2020)
13.7.5 Thermo Fisher Scientific Recent Development
13.8 HTG Molecular Diagnostics
13.8.1 HTG Molecular Diagnostics Company Details
13.8.2 HTG Molecular Diagnostics Business Overview
13.8.3 HTG Molecular Diagnostics MicroRNA Introduction
13.8.4 HTG Molecular Diagnostics Revenue in MicroRNA Business (2015-2020)
13.8.5 HTG Molecular Diagnostics Recent Development
13.9 Meridian Life Science
13.9.1 Meridian Life Science Company Details
13.9.2 Meridian Life Science Business Overview
13.9.3 Meridian Life Science MicroRNA Introduction
13.9.4 Meridian Life Science Revenue in MicroRNA Business (2015-2020)
13.9.5 Meridian Life Science Recent Development
13.10 Rosetta Genomics
13.10.1 Rosetta Genomics Company Details
13.10.2 Rosetta Genomics Business Overview
13.10.3 Rosetta Genomics MicroRNA Introduction
13.10.4 Rosetta Genomics Revenue in MicroRNA Business (2015-2020)
13.10.5 Rosetta Genomics Recent Development
13.11 Dharmacon
10.11.1 Dharmacon Company Details
10.11.2 Dharmacon Business Overview
10.11.3 Dharmacon MicroRNA Introduction
10.11.4 Dharmacon Revenue in MicroRNA Business (2015-2020)
10.11.5 Dharmacon Recent Development
13.12 BioVendor
10.12.1 BioVendor Company Details
10.12.2 BioVendor Business Overview
10.12.3 BioVendor MicroRNA Introduction
10.12.4 BioVendor Revenue in MicroRNA Business (2015-2020)
10.12.5 BioVendor Recent Development
13.13 Miltenyi Biotec
10.13.1 Miltenyi Biotec Company Details
10.13.2 Miltenyi Biotec Business Overview
10.13.3 Miltenyi Biotec MicroRNA Introduction
10.13.4 Miltenyi Biotec Revenue in MicroRNA Business (2015-2020)
10.13.5 Miltenyi Biotec Recent Development
13.14 Kaneka Corporation
10.14.1 Kaneka Corporation Company Details
10.14.2 Kaneka Corporation Business Overview
10.14.3 Kaneka Corporation MicroRNA Introduction
10.14.4 Kaneka Corporation Revenue in MicroRNA Business (2015-2020)
10.14.5 Kaneka Corporation Recent Development
13.15 Abcam
10.15.1 Abcam Company Details
10.15.2 Abcam Business Overview
10.15.3 Abcam MicroRNA Introduction
10.15.4 Abcam Revenue in MicroRNA Business (2015-2020)
10.15.5 Abcam Recent Development
13.16 GeneCopoeia
10.16.1 GeneCopoeia Company Details
10.16.2 GeneCopoeia Business Overview
10.16.3 GeneCopoeia MicroRNA Introduction
10.16.4 GeneCopoeia Revenue in MicroRNA Business (2015-2020)
10.16.5 GeneCopoeia Recent Development
13.17 Promega Corporation
10.17.1 Promega Corporation Company Details
10.17.2 Promega Corporation Business Overview
10.17.3 Promega Corporation MicroRNA Introduction
10.17.4 Promega Corporation Revenue in MicroRNA Business (2015-2020)
10.17.5 Promega Corporation Recent Development
13.18 New England Biolabs
10.18.1 New England Biolabs Company Details
10.18.2 New England Biolabs Business Overview
10.18.3 New England Biolabs MicroRNA Introduction
10.18.4 New England Biolabs Revenue in MicroRNA Business (2015-2020)
10.18.5 New England Biolabs Recent Development
13.19 NanoString Technologies
10.19.1 NanoString Technologies Company Details
10.19.2 NanoString Technologies Business Overview
10.19.3 NanoString Technologies MicroRNA Introduction
10.19.4 NanoString Technologies Revenue in MicroRNA Business (2015-2020)
10.19.5 NanoString Technologies Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Illumina、Roche、Agilent、Bio-Rad、Sigma Aldrich、Qiagen、Thermo Fisher Scientific、HTG Molecular Diagnostics、Meridian Life Science、Rosetta Genomics、Dharmacon、BioVendor、Miltenyi Biotec、Kaneka Corporation、Abcam、GeneCopoeia、Promega Corporation、New England Biolabs、NanoString Technologies

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のマイクロRNA市場2026:インサイト・予測(Global MicroRNA Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。